Article metrics

Download PDFPDF

Original research
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial

 

Online download statistics by month:

Online download statistics by month: October 2022 to October 2023

AbstractFullPdf
Oct 202226426497
Nov 2022763754231
Dec 2022195374195375581
Jan 202333813374143
Feb 202320602057119
Mar 202323242319126
Apr 202314711466113
May 202312451238140
Jun 20232027201997
Jul 20232183217387
Aug 202322792257114
Sep 202318801863104
Oct 202315811572130
Total2168322167312082